Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab

Joint Bone Spine

Volumn 77, Issue 3, 2010, Pages 271-273

  Moltó, Anna ^a   Mateo, Lourdes ^a   Lloveras, Natalia ^a   Olivé, Alejandro ^a   Minguez, Sonia ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anti TNF ; Macrophagic activation syndrome; Rheumatoid arthritis; Visceral leishmaniasis

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABDOMINAL PAIN; ADULT; AMASTIGOTE; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DRUG DOSE INCREASE; ECHOGRAPHY; FATIGUE; FEVER; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERGAMMAGLOBULINEMIA; IRON BLOOD LEVEL; JOINT STIFFNESS; LABORATORY TEST; LEISHMANIA; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MALE; PANCYTOPENIA; POLYARTERITIS; PROGNOSIS; RHEUMATOID ARTHRITIS; SPLENOMEGALY; THORAX PAIN; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL LEISHMANIASIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOCOMPROMISED HOST; LEISHMANIASIS, VISCERAL; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952545959     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.01.011     Document Type: Article

References (20)

1. Chappuis F., Sundar S., Hailu A., et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nat Rev Microbiol 5 (2007) 873-882
2. Hernández-Pérez J., Yebra-Bango M., Jiménez-Martínez E., et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 29 (1999) 918-921
3. Fernández-Guerrero M.L., Robles P., Rivas P., et al. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 90 (2004) 11-16
4. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24 (1997) 684-703
5. Sundar S. Diagnosis of kala-azar- an important stride. J Assoc Physicians India 51 (2003) 753-755
6. Sundar S., Singh R.K., Maurya R., et al. Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test. Trans R Soc Trop Med Hyg 100 (2006) 533-537
7. Gardam M.A., Keystone E.C., and Menzies R. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3 (2003) 148
8. Tumang M.C., Keogh C., Moldawer L.L., et al. Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol 153 (1994) 768-775
9. Nash P.T., and Florin T.H. Tumour necrosis factor inhibitors. Med J Aust 183 (2005) 205-208
10. Fabre S., Gibert C., Lechiche C., et al. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 23 (2005) 891-892
11. Bassetti M., Pizzorni C., Gradoni L., et al. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab. Rheumatology 45 (2006) 1446-1448
12. Bagalas V., Kioumis I., Argyropoulou P., et al. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 26 (2007) 1344-1345
13. Tektonidou M.G., and Skopuoli F.N. Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?. Clin Rheumatol 27 (2008) 541-542
14. Arlet J.B., Le T.H., Marinho A., et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 65 (2006) 1596-1601
15. Emmenegger U., Schaer D.J., Larroche C., et al. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 28 (2005) 299-314
16. Henter J.I., Elinder G., and Ost A. Diagnostic guidelines for haemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18 (1991) 29
17. Henter J.I., Horne A., Aricó M., et al. HLH-2004: Diagnostic and therapeutic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48 (2007) 124-131
18. Rajagopala S., Dutta U., Chandra K.S., et al. Visceral leishmaniasis associated haemophagocytic lymphohistiocytosis-case report and systematic review. J Infect 56 (2008) 381-388
19. Marthur P., Samantaray J.C., and Samanta P. Fatal haemophagocytic syndrome and hepatitis associated with visceral leishmaniasis. Indian J Med Microbiol 25 (2007) 416-418
20. Katoh N., Gono T., Mitsuhashi S., et al. Haemophagocytic syndrome associated with rheumatoid arthritis. Intern Med 46 (2007) 1809-1813